Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Turkey | 23 | 2023 | 237 | 1.320 |
Why?
|
| Coronary Disease | 14 | 2016 | 6077 | 0.930 |
Why?
|
| Capacity Building | 2 | 2019 | 248 | 0.550 |
Why?
|
| Research Personnel | 3 | 2019 | 573 | 0.540 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2013 | 56 | 0.470 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2013 | 31 | 0.460 |
Why?
|
| Hypertension | 8 | 2023 | 8480 | 0.450 |
Why?
|
| Tobacco, Smokeless | 2 | 2004 | 130 | 0.430 |
Why?
|
| Needs Assessment | 1 | 2014 | 1147 | 0.320 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5751 | 0.310 |
Why?
|
| Iodine | 1 | 2020 | 286 | 0.310 |
Why?
|
| Health Policy | 6 | 2019 | 2661 | 0.290 |
Why?
|
| Wales | 4 | 2005 | 85 | 0.260 |
Why?
|
| Chronic Disease | 2 | 2023 | 9146 | 0.250 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 15165 | 0.250 |
Why?
|
| England | 4 | 2005 | 522 | 0.230 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2203 | 0.220 |
Why?
|
| Public Health | 2 | 2019 | 2603 | 0.210 |
Why?
|
| Overweight | 1 | 2013 | 2371 | 0.210 |
Why?
|
| Risk Factors | 21 | 2023 | 72290 | 0.190 |
Why?
|
| Policy Making | 2 | 2014 | 554 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 11725 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2014 | 3309 | 0.160 |
Why?
|
| Obesity | 6 | 2022 | 12745 | 0.160 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2016 | 281 | 0.160 |
Why?
|
| Smoking | 8 | 2016 | 8987 | 0.160 |
Why?
|
| Meta-Analysis as Topic | 1 | 2003 | 1344 | 0.160 |
Why?
|
| Life Expectancy | 1 | 2005 | 1184 | 0.160 |
Why?
|
| Mortality | 5 | 2016 | 2864 | 0.160 |
Why?
|
| Decision Support Techniques | 2 | 2014 | 1956 | 0.150 |
Why?
|
| Professional Competence | 1 | 2019 | 447 | 0.130 |
Why?
|
| Fatigue | 1 | 2022 | 1531 | 0.130 |
Why?
|
| Age Distribution | 3 | 2005 | 2902 | 0.130 |
Why?
|
| Tunisia | 4 | 2016 | 33 | 0.120 |
Why?
|
| Stroke | 2 | 2016 | 9981 | 0.120 |
Why?
|
| Dyspnea | 1 | 2022 | 1303 | 0.120 |
Why?
|
| Female | 27 | 2022 | 380194 | 0.120 |
Why?
|
| Adult | 22 | 2022 | 214055 | 0.120 |
Why?
|
| Male | 27 | 2022 | 350118 | 0.120 |
Why?
|
| Humans | 41 | 2023 | 744343 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2022 | 2902 | 0.120 |
Why?
|
| Puumala virus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Hemorrhagic Fever with Renal Syndrome | 1 | 2013 | 2 | 0.110 |
Why?
|
| Urban Health | 2 | 2006 | 547 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2023 | 40561 | 0.110 |
Why?
|
| Vaginal Smears | 1 | 2016 | 511 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2014 | 1683 | 0.110 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2013 | 96 | 0.110 |
Why?
|
| Mediterranean Region | 3 | 2019 | 47 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2023 | 8554 | 0.100 |
Why?
|
| Middle East | 3 | 2019 | 219 | 0.100 |
Why?
|
| Hypercholesterolemia | 3 | 2007 | 1151 | 0.100 |
Why?
|
| Health Priorities | 1 | 2014 | 380 | 0.100 |
Why?
|
| Aged | 18 | 2016 | 163280 | 0.090 |
Why?
|
| Syria | 3 | 2016 | 76 | 0.090 |
Why?
|
| Middle Aged | 21 | 2016 | 213383 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2013 | 917 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2005 | 2297 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1530 | 0.080 |
Why?
|
| Finland | 1 | 2020 | 602 | 0.080 |
Why?
|
| Food, Fortified | 1 | 2020 | 191 | 0.080 |
Why?
|
| Ireland | 4 | 2012 | 161 | 0.080 |
Why?
|
| Health Promotion | 2 | 2014 | 2205 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 818 | 0.080 |
Why?
|
| Geography | 1 | 2020 | 669 | 0.080 |
Why?
|
| Physicians, Family | 1 | 2010 | 345 | 0.080 |
Why?
|
| Models, Statistical | 3 | 2016 | 5102 | 0.070 |
Why?
|
| Family Practice | 1 | 2010 | 516 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2022 | 3589 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1660 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6487 | 0.070 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 57776 | 0.070 |
Why?
|
| Risk Reduction Behavior | 3 | 2016 | 1125 | 0.070 |
Why?
|
| Prevalence | 4 | 2022 | 15226 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2006 | 128 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13989 | 0.070 |
Why?
|
| Immunotherapy, Active | 1 | 2006 | 60 | 0.070 |
Why?
|
| Time and Motion Studies | 1 | 2006 | 149 | 0.070 |
Why?
|
| Rabies | 1 | 2006 | 61 | 0.070 |
Why?
|
| Pregnant Women | 1 | 2020 | 568 | 0.060 |
Why?
|
| Exercise | 2 | 2016 | 5615 | 0.060 |
Why?
|
| Bites and Stings | 1 | 2006 | 91 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2014 | 5391 | 0.060 |
Why?
|
| Mammography | 1 | 2016 | 2476 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2148 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2016 | 2616 | 0.060 |
Why?
|
| Health Behavior | 2 | 2007 | 2636 | 0.060 |
Why?
|
| Incidence | 2 | 2022 | 20947 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 2020 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2005 | 236 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2012 | 1373 | 0.060 |
Why?
|
| Europe | 1 | 2020 | 3339 | 0.060 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2003 | 117 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2012 | 1859 | 0.050 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2071 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10262 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3022 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3086 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2020 | 1609 | 0.050 |
Why?
|
| Risk | 1 | 2013 | 9687 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2006 | 969 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2004 | 676 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3610 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2020 | 6459 | 0.050 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 7785 | 0.050 |
Why?
|
| Linear Models | 1 | 2020 | 5952 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 12720 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 10397 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 512 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2006 | 906 | 0.040 |
Why?
|
| Alcoholism | 1 | 2010 | 1906 | 0.040 |
Why?
|
| Cross-Sectional Studies | 4 | 2013 | 25043 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2021 | 571 | 0.040 |
Why?
|
| Triage | 1 | 2006 | 976 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2021 | 273 | 0.040 |
Why?
|
| Dietary Fats | 2 | 2016 | 2017 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2005 | 1167 | 0.040 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 601 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2014 | 4558 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 7939 | 0.040 |
Why?
|
| Psychometrics | 1 | 2006 | 3002 | 0.040 |
Why?
|
| Models, Cardiovascular | 3 | 2006 | 996 | 0.040 |
Why?
|
| Age Factors | 1 | 2013 | 18370 | 0.040 |
Why?
|
| Social Security | 1 | 2016 | 101 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1796 | 0.030 |
Why?
|
| Cholesterol | 1 | 2005 | 2917 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2016 | 2453 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2006 | 10252 | 0.030 |
Why?
|
| Developing Countries | 3 | 2014 | 2815 | 0.030 |
Why?
|
| Infant | 2 | 2013 | 35136 | 0.030 |
Why?
|
| Black Sea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2014 | 187 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 969 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2006 | 4245 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 63114 | 0.020 |
Why?
|
| Fruit | 1 | 2016 | 1142 | 0.020 |
Why?
|
| Vegetables | 1 | 2016 | 1182 | 0.020 |
Why?
|
| Developed Countries | 1 | 2012 | 437 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 13881 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 53288 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20822 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 29144 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2016 | 1809 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2540 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3218 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 1049 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 7659 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 40075 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 1011 | 0.020 |
Why?
|
| Rural Population | 1 | 2016 | 2210 | 0.020 |
Why?
|
| Curriculum | 1 | 2019 | 3605 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3870 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2003 | 21746 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1504 | 0.020 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5319 | 0.020 |
Why?
|
| Quality of Life | 1 | 2006 | 12804 | 0.020 |
Why?
|
| Child | 2 | 2020 | 77709 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11727 | 0.020 |
Why?
|
| Life Style | 1 | 2016 | 3835 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 840 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3188 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8324 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3912 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4560 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2006 | 2539 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 3508 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4371 | 0.010 |
Why?
|
| Urban Population | 1 | 2006 | 2021 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2010 | 3528 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 2161 | 0.010 |
Why?
|
| Adolescent | 3 | 2013 | 85781 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 3923 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2010 | 4687 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3255 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 24260 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15540 | 0.000 |
Why?
|
| Animals | 2 | 2013 | 168757 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 25625 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2006 | 23338 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2006 | 41006 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2006 | 77449 | 0.000 |
Why?
|
Concepts
(190)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_